Zobrazeno 1 - 10
of 259
pro vyhledávání: '"Post-progression survival"'
Publikováno v:
Journal of Hepatocellular Carcinoma, Vol Volume 11, Pp 1641-1652 (2024)
Xingzhi Li,1,2,* Zhihong Tang,1,* Qingqing Pang,1,* Xiaobo Wang,1 Tao Bai,1 Jie Chen,1 Meng Wei,1 Tao Wei,1 Lequn Li,1 Feixiang Wu1,3 1Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Re
Externí odkaz:
https://doaj.org/article/829722d1536141e8bf8085f57cb5fc7d
Autor:
D. V. Semenov, R. V. Orlova, V. I. Shirokorad, S. V. Kostritsky, M. I. Gluzman, S. G. Grigoriev, Yu. S. Korneva
Publikováno v:
Вестник урологии, Vol 11, Iss 2, Pp 110-121 (2023)
Introduction. Most patients with metastatic renal cell carcinoma (mRCC) who received systemic therapy are classified into as intermediate risk group according to the International mRCC Database Consortium (IMDC) assessment. However, survival differs
Externí odkaz:
https://doaj.org/article/575c1dc3bf704219bccaa1194e941fd6
Autor:
Ken Masubuchi, Hisao Imai, Satoshi Wasamoto, Takeshi Tsuda, Hiroyuki Minemura, Yoshiaki Nagai, Yutaka Yamada, Takayuki Kishikawa, Yukihiro Umeda, Ayako Shiono, Hiroki Takechi, Jun Shiihara, Kyoichi Kaira, Kenya Kanazawa, Hirokazu Taniguchi, Takayuki Kaburagi, Hiroshi Kagamu, Koichi Minato
Publikováno v:
Thoracic Cancer, Vol 13, Iss 19, Pp 2776-2785 (2022)
Abstract Background The effect of first‐line chemotherapy on overall survival (OS) may be significantly influenced by subsequent therapy for patients with extensive disease small cell lung cancer (ED‐SCLC). Therefore, we evaluated the relationshi
Externí odkaz:
https://doaj.org/article/64e6b20ba7e5445abb1fbb3bc51921e4
Autor:
Imai Hisao, Kobayashi Daijiro, Kaira Kyoichi, Kawashima Sayaka, Masubuchi Ken, Murata Masumi, Ebara Takeshi, Kitamoto Yoshizumi, Minato Koichi
Publikováno v:
Radiology and Oncology, Vol 56, Iss 2, Pp 228-237 (2022)
The efficacy of first-line chemoradiotherapy for overall survival (OS) might be confounded by the subsequent treatments in patients with locally advanced non-small cell lung cancer (NSCLC). In this study, we assessed the associations of progression-f
Externí odkaz:
https://doaj.org/article/33218a8ff93544ab8ffea031416e4099
Autor:
Hisao Imai, Ryoichi Onozato, Kyoichi Kaira, Sayaka Kawashima, Ken Masubuchi, Toshiteru Nagashima, Kohei Tajima, Koichi Minato
Publikováno v:
Thoracic Cancer, Vol 12, Iss 20, Pp 2740-2748 (2021)
Abstract Background For early‐stage non‐small cell lung cancer (NSCLC), surgical resection is considered the most effective treatment strategy and curative treatment. Unfortunately, even after complete resection, almost half of all patients with
Externí odkaz:
https://doaj.org/article/08dadcc489044b2c956b2a1a32a95dd7
Autor:
Changsen Leng, Yingying Cui, Junying Chen, Kexi Wang, Hong Yang, Jing Wen, Jianhua Fu, Qianwen Liu
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundEsophageal squamous cell carcinoma (ESCC) is characterized clinically by frequent recurrence, leading to a poor prognosis after radical surgery. The aim of this study was to identify a prognostic nomogram to predict the post-progression sur
Externí odkaz:
https://doaj.org/article/f91565bf7fc642149b3f1a6c03ec06a3
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundThe post-progression survival (PPS) of recurred intrahepatic cholangiocarcinoma (iCCA) patients relates to the characteristics of tumor progression. Moreover, the prediction model of PPS in those patients has not been well established. This
Externí odkaz:
https://doaj.org/article/eccb9d2e1a964472a0d1aa299240c4cb
Publikováno v:
The Korean Journal of Internal Medicine, Vol 35, Iss 6, Pp 1468-1476 (2020)
Background/Aims The prognosis of small cell lung cancer (SCLC) is still poor because of rapid recurrence, despite good response to initial chemotherapy. Additionally, patients’ old ages and comorbidities are often obstacles that make it difficult t
Externí odkaz:
https://doaj.org/article/7d56ff69057f4ef69e3ddb242e2e6802
Autor:
Felix Behling, Julia Rang, Elena Dangel, Susan Noell, Mirjam Renovanz, Irina Mäurer, Jens Schittenhelm, Benjamin Bender, Frank Paulsen, Bettina Brendel, Peter Martus, Jens Gempt, Melanie Barz, Bernhard Meyer, Marcos Tatagiba, Marco Skardelly
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectiveThe role of resection in progressive glioblastoma (GBM) to prolong survival is still controversial. The aim of this study was to determine 1) the predictors of post-progression survival (PPS) in progressive GBM and 2) which subgroups of pati
Externí odkaz:
https://doaj.org/article/8b50bbfa3b00498898b3bcae01137be7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.